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Abstract 
The exposure of organisms to environmental stresses and pathogens results in rapid activation 
of a range of defensive pathways that act as part of the innate immune system. The most 
common innate immunity response is the activation of cationic amphiphilic peptides in 
response to microbial infection. Moreover, cationic amphiphilic peptides possess desirable 
attributes for the pharmaceutical development of cancer-selective drugs. They selectively and 
rapidly kill cancer cells without killing normal mammalian cells and have a broad spectrum 
of mechanisms of action. The aim of this exploratory study was to screen for cationic 
amphiphilic peptides with anti-proliferative activity that is induced by genotoxicity. 
GeneFishing® technology, 2-D gel analysis and bioassays were used to identify and analyse 
molecules induced in response to genotoxic stress in an embryonic cell line originating from 
the dung beetle Euoniticellus intermedius. Bioassay results revealed that the cell line has 
constitutive expression of probable cationic amphiphilic proteins that are further induced by 
camptothecin treatment. GeneFishing® and 2-D gel analysis showed changes in gene 
expression at both transcriptional and translational levels, respectively. Overall, the study 
failed to identify the involvement or induction of cationic amphiphilic peptides in response to 
genotoxic stress. However, gene expression analyses revealed changes in the expression of 
classes of proteins involved in stress response, oxidative phosphorylation, mitochondrial 
maintenance, protein translation, cytoskeletal proteins and immunophilins. The results show 
that the cell line constitutively expresses probable cationic amphiphilic peptides which are 
further induced by camptothecin.  
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Chapter 1: Introduction 
1.1 Introduction 
 
The exposure of organisms to environmental stresses, toxins and pathogens results in rapid 
activation of a range of energy efficient defensive pathways that act as part of the innate 
immune system. The most common innate immunity response is the activation of peptides in 
response to microbial infection. This response is conserved from microorganisms to humans 
(Papo and Shai, 2003). These peptides are widely synthesised in areas of the organism that 
are regularly exposed to pathogens. For instance, dermicidin, a natural antibiotic is secreted 
with sweat and found on the surface of human skin (Paulmann et al., 2012). Most 
antimicrobial peptides are amphipathic and positively charged and are widely known as 
cationic amphiphilic peptides (CAPs) (Hancock, 2001). The above properties contribute to 
their ability to interact with and rapidly disrupt the negatively charged phospholipid 
membranes of microorganisms (Hancock, 2001; Leuschner and Hansel, 2004). Consequently, 
CAPs have antibiotic activity against a range of pathogenic bacteria, viruses, fungi and 
protozoa. Furthermore, they have selective anti-cancer toxicity (Lehmann et al., 2006). 
1.2 Cationic amphiphilic peptides overview 
 
CAPs range between 5–40 amino acids in length and are in most cases membrane active 
(Hoskin and Ramamoorthy, 2008; Hancock, 2001). Moreover, they can be classified into 
peptides that have toxicity against bacteria and viruses but not against mammalian cells and 
fungi; and those with toxicity against bacteria, viruses, fungi and mammalian cells (Papo and 
Shai, 2003). CAPs play a significant role in the innate immune system of a range of plants 
and animal species by acting as natural antibiotics against bacterial, enveloped viruses and 
fungal pathogens (Papo et al., 2003). They are also capable of acting synergistically with 
each other or other host immune molecules. For instance, magainin II and peptide PLGa have 
been shown to have synergistic toxicity in frogs, while lysozyme showed synergistic 
antibacterial toxicity with a range of conventional antibiotics (Hancock, 2001). Furthermore, 
they have the capacity to act as immune modulators for adaptive immunity in vertebrates 
(Hoskin and Ramamoorthy, 2008; Giuliani et al., 2007). For instance, human - and -
defensins have been established to exclusively chemo attract different groups of T 
lymphocytes and immature dendritic cells (Wu et al., 2003). CAPs have been proposed to be 
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involved in infection clearance and wound healing by acting as chemokines or by inducing 
chemokine production (Giuliani et al., 2007). Interestingly CAPs have cancer-selective 
toxicity linked to the electrostatic interactions between their net positive charge and the 
highly negative charge on cancer cells (Hoskin and Ramamoorthy, 2008). They are also 
capable of inducing apoptosis through interaction with the mitochondrion (Papo et al., 2003). 
Thus CAPs are potential candidates for anticancer drugs development since they have been 
reported to possess a novel mode of action, less cytotoxicity to normal cells and have a low 
likelihood of resistance development (Hsu et al., 2011). CAPs are synthesised in a range of 
cells such as epidermal, epithelial cells and neutrophils (Scot et al., 2008; Lohner and 
Prossnigg, 2009). 
1.3 Structure of CAPs 
 
CAPs are divided into four major secondary structural classes; α-helices, β-sheets connected 
by atleast one disulphide bridge, extended polyproline-like helices and loop structures 
(Ntwasa, 2012; Powers and Hancock, 2003) (Figure 1). The formation of secondary 
structures enables peptides residues to aggregate into an amphipathic structure that enables 
solubility in phospholipid membranes (Ntwasa, 2012). 
      
    
Figure 1: Structures and examples of peptides representing the four major classes of CAPs: (A) α-helical, 
magainin 2 (PDB ID: 2MAG); (B) β-sheet, lactoferricin B (PDB ID: 1LFC); (C) Loop, thanatin (PDB ID: 
8TFU); (D) Extended, indolucidin (PDB ID: 1G89). The 2-D images were generated with swis PDB viewer.  
A B 
C D 
- 3 - 
 
1.4 Cationic amphiphilic peptides structural-functional relationships 
 
Despite a variety of sequences and structures, CAPs share common features such as 
biochemical properties, antimicrobial and anticancer activities (Hoskin and Ramamoorthy, 
2008).  
 
They are linear peptides, generally unstructured in solution, amphipathic and positively 
charged due to a high content of basic lysine and arginine residues. As previously mentioned 
these properties result in the rapid disintegration of negatively charged phospholipid 
membranes (Hancock, 2001; Leuschner and Hansel, 2004). The overall positive charge of 
CAPs is believed to be crucial in facilitating electrostatic interaction between the peptide and 
anionic lipopolysaccharides of the membrane during the initial binding (Powers and 
Hancock, 2003). Furthermore, they are capable of integrating into the phospholipid 
membrane due to their amphiphilicity, resulting in rapid disruption of the membrane 
(Paulmann et al., 2012). In addition, the induction of α-helices, β-sheets, extended 
polyproline-like helices and loop secondary structures in a hydrophobic environment 
enhances the amphipathicity of CAPs (Hoskin and Ramamoorthy, 2008; Powers and 
Hancock, 2003). The carpet model, barrel-stave model, toroidal-pore worm model and 
detergent-like membrane lytic mechanism have been used to describe the mode of action of 
CAPs’ membrane disruption. The membrane disruption property of CAPs has been 
established to be dependent on a range of physicochemical properties such as the amino acid 
sequence, net charge, amphipathicity and structural folding in membranes (Hoskin and 
Ramamoorthy, 2008; Hsu et al., 2011). 
 
1.5 Mechanisms of action of CAPs 
1.5.1 Overview 
The membrane-selective toxicity of CAPs has been linked to the electrostatic interactions 
between their net positive charge and the negative charge of membranes, secondary structure 
conformation and the amphipathic nature of the peptides (Jang et al., 2011; Lohner and 
Prossnigg, 2009).  
The mechanisms of cell necrosis are localised on the cell membrane and involve either pore 
formation or disruption of membrane integrity (Maher and Mclean, 2004). Disruption of the 
membrane integrity is a result of alterations in the phospholipid bilayer architecture and thus 
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leads to the leakage of cytoplasmic contents (Chen et al., 2010). Interestingly the peptides are 
able to discriminate between different lipid components of cell membranes which ultimately 
enhance selectivity (Lohner and Prossnigg, 2009). Furthermore, electrostatic interactions 
facilitate the adsorption of the peptide to the membrane which is followed by conformational 
changes of the unstructured peptide into a more amphipathic molecule with a defined 
secondary structure. The active peptide interacts with the hydrophobic core leading to 
membrane disruption and/or membrane potential disturbance (Drechsler and Andre, 2011; 
Lohner and Prossnigg, 2009).  Javadpour et al., (1999) showed that a leucine/alanine, 21-mer 
peptide had an increased propensity to form helical conformations in amphipathic 
environments and ultimately increased toxicity against immortalised mouse fibroblast cells, 
compared to 14-mer peptides and glycine rich 21-mer peptides. The above study 
demonstrates the significance of the secondary structure conformation and amphipathicity in 
membrane disruption (Drechsler and Andre, 2011; Javadpour et al., 1999). Moreover, 
displacement of divalent ions such as Mg
2+
 and Ca
2+
 from membrane surfaces destabilises the 
membrane and facilitates binding regions for the peptides (Giuliani et al., 2007) 
Several models have been proposed to explain the membrane-localised selective activity of 
CAPs (Figure 2). Membrane lysis is a result of peptide aggregation on the membrane and 
formation of ion-channel pores. Furthermore, membrane disintegration leads to 
depolarisation of the membrane potential (Papo and Shai, 2003).  
 
(Hoskins and Ramamoorthy, 2008) 
Figure 2: Models for CAPs membrane permeabilisation. Depending on the mechanism, peptides can either 
oligomerise before interacting with the membrane or oligomerise in the membrane.    
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1.5.2 The carpet model 
 
The carpet model proposes that peptides accumulate and bind on the surface of the 
phospholipid membrane and then integrate into the membrane after reaching a given 
threshold level. The permeation varies depending on the type of peptide, with mechanisms 
such as detergent-like disintegration and channel aggregate formation. The interaction 
between the membrane and peptides is predetermined by hydrophobic charges (Hancock, 
2001; Papo and Shai, 2003). The disturbance of membrane integrity results in the leakage of 
cytoplasmic contents, disturbance of the membrane potential and consequently the 
disintegration of the membrane. Furthermore, the rapid depolarisation of the target cells leads 
to rapid death (Powers and Hancock, 2003).  
 In the detergent-like mechanism, peptides spread on the surface of the membrane in an 
orientation parallel to the phospholipid bilayer head region. The peptides aggregate to a 
threshold concentration giving the peptide aggregate a highly amphipathic character that 
enables the peptides to act like a detergent thereby breaking the phospholipid membrane into 
micelles or bicelles-like small fragments (Hoskin and Ramamoorthy, 2008). 
1.5.3 The toroidal-pore model 
 
The toroidal-pore mechanism involves the orientation of peptides parallel to the phospholipid 
bilayer surface before they are eventually located in proximity to the head region of the 
phospholipid bilayer. The latter positioning facilitates the interaction between the hydrophilic 
side of the helix with the hydrophilic lipid head groups and the water phase outside bilayer, 
while the hydrophobic phase of the helix is embedded in the hydrophobic region of the lipid 
layer. Local aggregation of the peptides on the membrane surface increases until a threshold 
level is reached; and this increases the potential of toroidal-pore formation (Hoskin and 
Ramamoorthy, 2008).   
1.5.4 The barrel starve model 
 
Peptides aggregate in the membrane by aligning parallel to the phospholipids ultimately 
forming an ion-channel pore (Hoskin and Ramamoorthy, 2008). The membrane bound 
peptides are capable of recognising each other and then oligomerise to form the ion-channel 
pore. Moreover, the amphipathicity and secondary structure conformation of the peptides 
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play a significant role in pore formation. Peptides that use this mechanism are capable of 
interacting strongly with both zwitterionic and negatively-charged membranes and are 
consequently non-selective (Giuliani et al., 2007; Papo and Shai, 2003).  
1.5.5 The aggregate or channel-forming model 
 
The aggregate model proposes that membrane permeabilisation is dependent on the 
oligemerisation of the peptides within the membrane without a fixed stoichemistry. The 
oligemerisation is concentration and voltage dependant, and ultimately follows a sigmoidal 
curve. Electrostatic interactions have been established to play a significant role in the initial 
interaction (Ntwasa, 2012).  
1.6 CAPs interaction with subcellular targets 
 
Although the primary target of CAPs toxicity is the cell membrane, they have been described 
to translocate across the membrane and cause mitochondria morphological distortions and 
inhibit energised mitochondria in fungi. Some peptides have been proposed to result in the 
blockage of virus-cell fusion and the activity of HIV long terminal repeats. In some instance, 
peptides are translocated into the cytoplasm where they have enzyme targets (Hancock, 
2001). An antibacterial peptide, ABP-CM4 has been reported to have significant antifungal 
activity through the disruption of cell membrane architecture, the cytoskeleton, and 
interaction with the mitochondrion and deoxyribonucleic acid (DNA) (Chen et al., 2010). 
CAPs have also been reported to interact and interfere with the synthesis of DNA and 
ribonucleic acid (RNA) in bacteria (Powers and Hancock, 2003). Furthermore, nisin A and 
gallidermin from Lactococcus lactis and Streptococcus gallinarium, respectively, have been 
reported to inhibit peptidoglycan synthesis (Maher and McClean, 2006).  
1.7 The role of CAPs in apoptosis 
 
Some CAPs have been reported to induce apoptosis through interaction with the host 
mitochondrion (Maher and McClean, 2006). This is directly linked to their ability to 
translocate across the lipid bilayer into the cytoplasm and other organelles (Terrone et al., 
2003). 
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It has been established that CAPs translocate across the lipid bilayer via a gradient and 
composition dependant mechanism with minimal disruption to the integrity and permeability 
of the membrane (Terrone et al., 2003). The CAP, (KLAKLAK)2 has been demonstrated to 
disrupt plasma and mitochondrial membranes, and subsequently induce caspase-independent 
and caspase-dependent cell death, respectively. The -helical peptide nanostructure has been 
established to be highly stable, membrane permeable and capable of inducing caspase-
independent and Bax/Bak-independent apoptosis in breast cancer cells with minimal potency 
to normal cells (Standley et al., 2010). Human antimicrobial peptide, cathelicidin LL-37 has 
been reported to induce apoptosis in vitro in human lung epithelial cell line A549. The 
peptide induced caspase-dependant cell apoptosis in a dose-dependent manner. Furthermore 
disruption of cell membrane integrity and cell death was limited to tumour cells only (Lau et 
al., 2010).  
1.8 The expression of CAPs in response to stress and roles in immunity 
1.8.1 CAPs synthesis and modification 
 
CAPs are principally synthesized in the skin, eyes and lungs since these tissues are 
significantly exposed to pathogens (Papo and Shai, 2006). They are either synthesised and 
stored in these specialised cells and released as a result of infection or their synthesis and 
secretion is triggered by infection (Martin et al., 1995). Human -defensin-1 is constitutively 
expressed in intestinal epithelial cells while the expression of -defensin-3 is induced as a 
result of wounding or injury (Yeung et al., 2011). 
Mammals synthesize and secrete CAPs in the skin, mucosal surfaces and neutrophils and 
these facilitate local response to infection (Scot et al., 2008; Yeung et al., 2011). For instance, 
dermicidin is a human antibacterial peptide with a broad spectrum of toxicity, which is 
synthesised in the eccrine sweat glands, secreted into sweat and is transported to the skin 
surface during sweating. Dermcidin is constitutively expressed as a full length 110 amino 
acid peptide with an N-terminal 19 amino acid signal peptide. The peptide is further 
differentially processed into C-terminal peptides of 47 amino acid residues or less. The 
peptide has been reported to have in vitro toxicity against pathogens such as, Staphylococcus 
aureus, Escherichia coli, Enterococcus faecalis and Candida albicans. Human cathelicidin 
LL-37 and human -defensin (hBD-2) are expressed in neutrophils and keratinocytes, 
respectively, in response to injury and inflammation (Reig, et al., 2004), while human β-
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defensin-1 (hBD-1) is constitutively expressed in the epithelial cells of the intestines (Yeung 
et al., 2011). 
 In amphibians, such as the South African clawed frog, Xenopus laevis, the antimicrobial 
peptide magainin II is synthesized and secreted in the granular skin glands and 
gastrointestinal tract (granular cells) (Lehmann et al., 2006; Lohner and Prossnigg, 2009). 
Both magainin I and II have been reported to be synthesised and stored in granular skin 
glands in frogs and consequently released to the skin surface in response to skin injury or 
exposure to pathogens or toxins. Furthermore, isolation of magainin cDNA has led to the 
conclusion that both magainin I and II are encoded by a single precursor (Reilly et al., 1994).  
CAPs are synthesized as protein precursors with a generally conserved precursor region, 
highly diverse biologically active region and an endoplasmic reticulum targeting signalling 
peptide (Martin, et al., 1995; Patrzykat and Douglas, 2003). Moreover, CAPs are single gene-
encoded peptides (Patrzykat and Douglas, 2003), and can be either ribosomally or non-
ribosomally synthesized (Scot et al., 2008).  
Cathelicidin-associated antimicrobial peptides are ribosomally synthesised peptides with a 
conserved precursor region of approximately 100 amino acid residues, and with homology to 
cysteine protease inhibitor, cathelicidin. Moreover, the highly diverse C-terminal cationic 
antimicrobial domain is cleaved off during formation of the mature antimicrobial peptide 
known as cathelicidin (Nissen-Meyer and Nes, 1997).  Post-translational modifications of 
CAPs include the formation of disulphide bonds, C-terminal amidation, N-terminal 
pyroglutamic acid formation and, in a few cases, glycosylation. These modifications 
contribute to the stability and activity of some CAPs. Furthermore, multiple isoforms of a 
peptide can be derived by N-terminal truncation. CAPs may also be cleavage products of 
larger molecules, such as histones and ribosomal proteins (Patrzykat and Douglas, 2003).  
1.8.2 Signalling pathways involved in CAPs response and action 
 
Injury, inflammation and microbial pathogenicity determinants induce the expression of 
CAPs as a first line of defence (Leuschner and Hansel, 2004; Yeung et al., 2011). 
Furthermore, local CAP synthesis can be increased rapidly through degranulation of 
phagocytes or via Toll receptor-mediated pathways (Patrzykat and Douglas, 2003).  
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Wounding and exposure to pathogen-associated molecular patterns such as 
lipopolysaccharides trigger innate immune pathways that induce the synthesis and secretion 
of CAPs. Injury or exposure to bacterial endotoxins induces the production and secretion into 
blood of a range of antibacterial peptides from insect blood cells and fat cells. This immune 
response resembles the mammalian immune response and acute-phase response since gene 
expression is regulated by a kB-related cis-regulatory motif and by an NF-kB-related 
transcription factor (Nissen-Meyer and Nes, 1997).  
Bacterial endotoxins, lipopolysaccharides, lipoteichoic acids and unmethylated CpG DNA 
are capable of interacting with Toll-like receptors triggering a range of host signalling 
pathways. Such an interaction has been linked to the up-regulation of apoptosis inducing 
factors (tumour necrosis factors), pro-inflammatory and anti-inflammatory (interleukin 6) 
cytokines, and chemokine-like inflammatory proteins. CAPs are capable of suppressing the 
up-regulation of these pathways and prevent endotoxaemia by binding directly to the 
endotoxins or receptors (Hancock, 2001). For instance, the peptide ABP-CM4 from the 
Chinese silk worm, Bombyx mori has been demonstrated to be capable of preventing 
lipopolysaccharides from binding to CD14+ and consequently preventing the production of 
cytokines and nitric oxide (Chen et al., 2010). Furthermore, the immunomodulation of human 
peptide, cathelicidin LL-37’s is mediated by inducing the phosphorylation of mitogen-
activated protein kinase (MAPK), extracellular signal-regulated kinase ½ (ERK ½) and p38 
kinase. This peptide is also able to stimulate innate immunity effector cells through a formyl 
peptide-like receptor 1 (FPRL-1). FPRL-1 is a pertussis toxin sensitive, G protein-coupled 
receptor that has been reported to be the chemotactic receptor on neutrophils, T-cells subsets 
and monocytes (Bowdish, 2004).  
Microbial lipopolysaccharides and lipotechoic acid induce immune response in airway 
epithelial lining via interaction with Toll-like receptors. Rhinovirus double stranded 
ribonucleic acid has been reported to be a ligand for Toll-like receptor 3. Rhinovirus infection 
induces increased expression of human β-defensins 2 and 3, and chemokines. Moreover, 
Toll-like receptor 9 facilitates the expression of interleukin-8 from colony epithelial cells in 
response to bacterial infection. Distinct types of Toll-like receptors from a range of cells 
induce unique signalling pathways that are specific to both cell type and microbe. For 
instance, Toll-like receptors and interleukin-1 receptors bind to the MyD88 adaptor molecule 
through the Toll-interleukin-1 domain. MyD88 recruits and results in the phosphorylation of 
serine/threonine kinase interleukin-1 receptor associated kinase and the latter consequently 
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interacts with TRAF6. TRAF6 mediates downstream signalling to mitogen activated protein 
kinases and transcription factors (Bals and Hiemstra, 2004). 
1.9 Roles in innate immunity 
 
As previously stated CAPs contribute to the  first line of defence against bacterial, viral, 
protozoa and fungal infections and play a significant role in innate immunity (Hoskins and 
Ramamoorthy, 2008; Hsu et al., 2011; Torrent et al., 2007). Moreover, they provide the 
defence mechanism against infection in insects and plants which lack the T-cell and antibody 
based adaptive immunity (Scot et al., 2008). These peptides are toxic against a range of 
bacterial pathogens including drug resistant strains such as Pseudomonas aeruginosa, 
Staphylococcus aureus and Stenotrophonomas maltophilia, with minimum inhibitory 
concentrations in the range of 1-4µg\ml, but many are not toxic to mammalian cell 
membranes. Moreover, they have been reported to have antifungal activity via morphology 
integrity distortion and mitochondrion induced apoptosis (Hancock, 2001; Yeung et al., 
2011). For instance, rabbit defensin NP-2 has been reported to cause permeabilisation in 
yeast Candida albicans (Hancok, 2001). Magainin has been reported to have a broad 
spectrum of toxicity and to be active against both Gram-positive and Gram-negative bacteria, 
fungi and protozoa (Matsuzaki, 1998). CAPs such as defensins, melittin and polyphemusin, 
have been reported to have antiviral activity (Hancok, 2001). Dermaseptin has been shown to 
be directly active against the human immunodeficiency virus (HIV) through interaction with 
and destabilisation of the viral envelope while the polyphemusin analogue T22 blocks the 
entry of chemokine receptor-dependant HIV strains into cells by interaction with the 
chemokine receptor CXCR4 on T cells (Yeung et al., 2011). Other peptides have been 
reported to be capable of blocking virus cell fusion (Hancok, 2001).  
1.10 Immunomodulatory roles of CAPs 
 
Cationic peptides are also involved in innate immunity through stimulating the chemo-
attraction of monocytes and neutrophils, promotion of histamine release from mast cells, 
inhibition of tissue proteases and stimulation of wound healing (Hancock, 2001). 
Interestingly CAPs have been found to be capable of modulating the host immune response 
and inducing the adaptive immune response through stimulating the production of immune 
mediators and signalling molecules (Bechinger, 2010; Hoskins and Ramamoorthy, 2008; 
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Patrzykat and Douglas, 2003; Torrent et al., 2007). Human defence peptides, such as 
cathelicidin LL-37, have been established to selectively enhance and modulate the host 
immune system through a range of activities including direct stimulation of chemotaxis 
and/or through chemokine production, suppression of the synthesis of bacterial induced pro-
inflammatory cytokines, regulation of neutrophil and epithelial cell apoptosis, modulation of 
cellular differentiation pathways, modulation of dendritic cell activation and differentiation, 
and promotion of angiogenesis and wound healing (Lau et al., 2004; Yeung et al., 2011). 
Moreover, peptides such as melittin and defensins participate in acute and chronic 
inflammation in humans (Patrzykat and Douglas, 2003). For instance, hBD-3 is expressed in 
response to inflammatory disorders such as Crohn’s disease (Yeung et al., 2011). 
1.11 Anti- cancer activity of CAPs 
 
Currently, to our knowledge, there is no information on the signalling pathways for CAPs in 
response to genotoxic stress. However, a range of CAPs from different organisms have been 
shown to have anti-proliferative activity against cancer cells (Shcweizer, 2009).  
CAPs have been reported to possess cancer selective-toxicity through a range of mechanisms. 
The peptides are capable of inducing cell death via mitochondrial membrane disruption, 
inhibition of blood vessel development thus preventing tumour progression and necrosis 
induction (Chen et al., 2010). The mechanisms of cell necrosis are localised on the cell 
membrane and involve either pore formation or disruption of membrane integrity (Maher and 
Mclean, 2004). 
Changes in the membrane of cancer cells are significant for cancer progression without 
signals that normally control growth. These changes ultimately result in fundamental 
differences between cell membranes of malignant and normal cells and this has been 
proposed to result in the selective toxicity to cancer cells by CAPs (Hoskin and 
Ramamoorthy, 2007). The cancer-selective toxicity of CAPs has been linked to the 
electrostatic interactions between their positive charge and the highly negative charge on 
cancer cells (Hoskin and Ramamoorthy, 2007). The net negative charge on cancer cells is due 
to the increased expression of anionic molecules such as phosphatidyl serine and O-
glycosylated mucins. Furthermore, the negative membrane potential contributes to the 
selective cytotoxicity. Conversely electrostatic interaction between CAPs and normal 
mammalian cell membrane is not favourable because the latter is composed largely of 
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zwitterionic phospholipids such as phosphatidylethanolamine, phoshatidylcholine and 
sphingomyelin resulting in a net neutral charge. Moreover, the cholesterol on the membrane 
interferes with the CAPs permeabilisation and disruption of the lipid bilayer (Hoskin and 
Ramamoorthy, 2007). 
 
Chen et al., (2010) studied the in vitro anticancer activity of the cationic amphiphilic 
antibacterial peptide-CM4 (ABP-CM4) against human leukemia cells compared to normal 
mammalian cells; human embryonic kidney cell line (HEK-293) and mononuclear cells 
(PBMCs). The peptide was isolated from the haemolymph of the Chinese silkworm Bombyx 
mori. Conformational studies using circular dichroism showed that ABP-CM4 had a 
significant random coil conformation in water. Inversely, the peptide showed an increasingly 
characteristic α-helical secondary structure in 20% v/v 2,2,2-trifluoroethanol (TFE) in water 
and a well-defined α-helical conformation in 30 % and 50% v/v TFE in water. Furthermore, 
the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) colometric 
assay results indicated dose-dependent cytotoxicity of ABP-CM4 against leukemia cells. The 
standard MTT assay measures cell viability after exposure to a growth inhibitor. The IC50 
values of ABP-CM4 in inhibiting THP-1, K562 and U937 cells were about 14.2, 15.8 and 
17.5 µM, respectively. Interestingly, the peptide showed no significant cytotoxicity against 
HEK-293 cell line and PBMCs even at the highest concentration evaluated, 80 µM. Trypan 
blue exclusion assays also confirmed that ABP-CM4 showed no significant cytotoxic activity 
against PMBCs at a concentration more than tenfold the IC50 obtained against leukemia cells. 
The results demonstrated selective cytotoxicity against leukemia cells (Chen et al., 2010).  
 
A flow cytometry analysis showed that FITC-labelled ABP-CM4 had a high affinity for the 
cell membrane of leukemia cells as indicated by higher fluorescence compared to normal cell 
lines. Moreover, the increase in fluorescence was proportional to the peptide concentration 
(Chen et al., 2010). Confocal laser scanning microscopy examination further confirmed that 
ABP-CM4 interacts with and binds to the cytoplasmic membrane since the FITC-labelled 
ABP-CM4 was localized on cell surfaces (Chen et al., 2010). LDH release assay and 
fluorescent propidium iodide (PI) uptake assay indicated a cell membrane damage 
mechanism of ABP-CM4 against leukemia cells. The levels of LDH release and fluorescent 
PI uptake where proportional to the concentration of the peptide used to treat the cells (Chen 
et al., 2010).  
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Hsu et al., (2011) demonstrated that synthetic Pardaxin induced apoptosis enhances its 
antitumor activity in human fibrosarcoma cell line (HT-1080) and epithelial carcinoma cell 
lines (HeLa). Pardaxin is a 33-amino acid pore-forming toxin from the Red Sea Moses sole, 
Pardachirus marmoratus. The study showed that Pardaxin inhibited the proliferation of HT-
1080 and HeLa cells in a dose-dependent manner after a 6-24 hour exposure at concentrations 
between 6-50µg/ml. The anti-proliferative effect of Paradaxin on HT-1080 cells was at the 
highest levels 6 hours after treatment. However, HeLa proliferation was inhibited after 24 
hours. DNA fragmentation studies showed DNA fragmentation in HeLa cells and not in HT-
1080 after exposure to 15µg/ml of pardaxin. LDH release assay showed that LDH release 
from HeLa and HT-1080 cells was dose dependent. This showed that pardaxin disrupted the 
cytoplasmic membrane integrity of HeLa and HT-1080 cells. Pardaxin had no effect on the 
cytoplasmic membranes of human red blood cells (HRBCs). Moreover, flow cytometry 
indicated an increased proportion of HeLa cells in the subG1 phase. The above results imply 
that pardaxin induces apoptosis in HeLa cells and not in HT-1080. Furthermore, Real-time 
reverse-transcription polymerase chain reaction analysis showed that pardaxin induces the 
synthesis of cytokines, down regulates the expression of invasion-related genes and probably 
has pleiotropic effects on different cells (Hsu et al., 2011).       
 
Several other CAPs have been found to exhibit anti-proliferative activity against different 
cancer cell lines. Lehmann et al., (2006) established the antitumor activity of the 
antimicrobial peptide magainin II against bladder cancer cell lines (RT4, 647V and 486P) 
with a mean LC50 value of 198.1µM. Cecropins are a class of α-helical antimicrobial peptides 
derived from insects and have also been established to have cytotoxic effects on HL-60 
human promyelocytic leukemia cell lines, in particular cecropin B1 (Hoskin and 
Ramamoorthy, 2008). Papo et al., (2003) designed a short cationic diastereomeric peptide 
composed of D- and L-leucines, lysines, and arginines that showed selective toxicity towards 
mouse melanoma, fibroblast and lung carcinoma cells and significantly inhibited lung 
metastasis in about 86% of mice, with no detectable side effects. The peptides displayed the 
ability to depolarize the membrane potential rapidly at a concentration of about 3 µM. 
Moreover, confocal microscopy studies verified that the cells died as a result of acute injury, 
swelling, and bursting thus, suggesting necrosis.  
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1.12 Development of CAPs as therapeutic agents 
 
CAPs possess desirable attributes for the pharmaceutical development of cancer-selective 
drugs. They selectively and rapidly kill cancer cells without killing normal mammalian cells 
and have a broad spectrum of mechanisms of action (Ntwasa, 2012). However, most of the 
well-studied and documented CAPs for cancer-selective toxicity have been isolated from 
amphibians and marine organisms (Hoskin and Ramamoorthy, 2007). Moreover, they are 
secreted in response to microbial infection and injury (Leuschner and Hansel, 2004). Several 
challenges have been established to impede the therapeutic development of commercially 
viable peptide-based drugs (Ntwasa et al., 2012). Foreign CAPs may have great potential to 
elicit treatment-neutralizing antibodies and/or potentially dangerous allergic responses in 
cancer patients.  They are also prone to proteolysis and inactivation in blood serum resulting 
in a short half-life in vivo thus hampering their systemic use. For instance, blood serum 
strongly inhibits HNP-mediated cytotoxicity and this is an obstacle to the systemic 
administration of these human α-defensins. Synthetic CAPs such as DP-1 and r7-kla that 
have been engineered for rapid cellular uptake and resistance to proteolysis require selective 
targeting to tumour sites to enhance cancer-selective toxicity following systemic 
administration. In addition, the exorbitant production cost of synthetic CAPs is a huge 
obstacle to their development as anticancer agents. It has been established that magainin II, 
isolated from a frog species, showed reduced cytotoxicity against a differentiated bladder 
cancer cell line in comparison to the undifferentiated cell line (Lehmann et al., 2006). The 
low toxicity to certain neoplastic cells observed in some studies may require frequent 
administration to keep doses high if those peptides are to be used as anticancer agents. 
Moreover, the low cytotoxicity observed against normal cells and the hemolysis of 
erythrocytes need to be taken into consideration if CAPs are to be further studied and 
developed for cancer-selective toxicity. 
1.13 Review of the SAEIE08 cell line 
 
SAEIE08 is a dung beetle E. intermedius embryonic cell line developed by Rodney Hull from 
the Flylab, University of the Witwatersrand. The karyotype of the beetle was established to 
be 2n = 23 + XY, resembling the majority of the Coleoptera species. The cell was reported to 
divide asymmetrically into two daughter cells of different sizes, with a doubling time of 
approximately 5 hours. The cell line rapid growth at 26
o
C may be a result of the early 
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expression of cytokine, Unpaired-3, leading to the early induction of the JAK-STAT pathway 
in embryonic cell line (Alouna, 2012).  
1.14 Camptothecin as a DNA damaging agent 
 
Camptothecin (CPT), is an alkaloid that is often used as an anticancer agent as it is an 
inhibitor of DNA topoisomerase I and thus disrupts the process of DNA replication. 
Camptothecin is, therefore a genotoxic stressor (Seong et al., 2012). Topoisomerases are 
enzymes that regulate the level of DNA supercoiling, to facilitate interaction with proteins 
during replication and transcription. These enzymes bind to either single stranded or double 
stranded DNA and their actions result in temporary breaks to DNA during replication, 
transcription, recombination and chromatin remodelling (Champoux, 2001). Seong et al., 
(2012) reported that CPT binds to the topoisomeraseI-DNA complex introducing irreversible 
covalent linkage that prevents re-sealing of the topoisomerase 1 introduced DNA breaks. This 
causes replication-dependent double-strand breakages in the DNA of replicating cells. Thus 
the CPT-DNA-topoisomerase complex disrupts replication and causes unfavourable DNA 
topology leading to homologous and non-homologous recombination. DNA damage and/or 
the failure to repair the damage induce DNA repair pathways which are controlled by a range 
of genes including tumour response genes (Davis and Lin, 2011). 
Drosophila melanogaster (Canton S) has been used as model system to study the effects of 
CPT on normal cells. In a previous study, CPT treatment was established to cause an increase 
in the transcription of the Drosophila homologue of p53 (Dmp53) revealing the activation of 
the p53 pathway. In this study, the transcription of a Drosophila member of the 
retinoblastoma binding protein 6 family, Snama, was reduced during CPT treatment, but up-
regulated when the flies recovered from treatment. This up-regulation may be associated with 
glycolytic flux that was induced in recovering flies (Hull and Ntwasa, 2010). In another 
study, Dmp53 was reported to have roles in DNA damage-induced cell cycle arrest under 
specific circumstances and tissue regeneration in response to imaginal discs damage (Monk et 
al., 2012). Dmp53 is known to induce apoptosis by up-regulating the transcription of 
downstream effectors such as reaper, head involution defective and sickle. In this study CPT 
is therefore considered a suitable model for DNA damage since there is background 
information about its effect on insects. CPT does, however, have some disadvantages; it is 
insoluble in water and is solubilised here in DMSO which may also have adverse effects on 
cells. 
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1.15 Objectives of the study 
 
The current study is exploratory and aims to screen for genotoxic induced CAPs of insect 
origin with increased anti-proliferative activity against cancer cells, no toxicity to normal 
mammalian cells and resistant to proteolysis. 
The current study focused on the identification and characterisation of molecules induced in 
response to genotoxic stress from an embryonic cell line originating from the dung beetle 
Euoniticellus intermedius. Moreover, it is important to establish if the induction of CAPs 
expression is part of the response. E intermedius (Coleoptera: Scarabaeidae) is a well-known 
dung beetle found largely in the Afrotropical region. E intermedius has a wide ecological 
tolerance and survives under extreme environments and has been reported to be tolerant to a 
range of conventional pesticides (Kruger et al., 1999). The beetle is being studied in the 
Flylab as a model of innate immunity in coleopterans.  
The objectives of the study are:  
 To isolate camptothecin induced cationic amphiphilic peptides using a C18 column 
 To assay for potential anti-proliferative activity of induced CAPs using radial 
diffusion assay as a model 
 To evaluate differential gene expression following camptothecin treatment using the 
GeneFishing® technology 
 To evaluate differential protein expression using 2-D gel electrophoresis 
 To identify differential expressed proteins using mass spectroscopy 
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Chapter 2: Materials and methods 
2.1 Materials 
 
The materials used in this study are listed in the tables below. The materials were grouped 
into three categories: media, biological buffers and solutions, and primer. 
Table 1: Media 
Media Composition/ supplier 
Grace’s Insect media Highveld  Biological (catalogue # L16) 
Luria broth 1% Sodium chloride (Merck, Germany) 
1% Tryptone ( Biolab) 
0.5% Yeast extract (Biolab) 
Solid agar 1% Sodium chloride (Biolab) 
1% Tryptone (Biolab) 
0.5% Yeast extract (Biolab) 
1.5% Agar (Biolab) 
Tryptic soy broth 3% Tryptic soy (Biolab) 
Underlay agar 0.03% Tryptic Soy Broth (Biolab) 
1% Agarose (Biolab) 
0.02% Tween (Merck Germany) 
Overlay agar  6% Tryptic soy (Biolab) 
1% Agarose (Biolab) 
 
Table 2: Biological buffers and solutions 
Buffer/solution Composition 
50X TAE electrophoresis buffer pH 8 24.2 w/v % Trisbase (Merck, Germany) 
5.71 v/v % Glacial acetic acid (Merck) 
3.72 w/v  % Na2EDTA.2H2O (Merck) 
Buffer I 50mM glucose (Merck, Germany) 
10mM EDTA (Merck, Germany) 
0.25M TrisHCl pH 8 (Merck, Germany) 
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Buffer II 1% SDS (Prolabo catalogue #27926.238) 
0.2N NaOH (Merck, Germany) 
Buffer III 5M Potassium acetate (Merck, Germany) 
Ethanol : Acetate 25 : 1 (Merck, Germany) 
Camptothecin 50mM in DMSO (Merck, Germany) 
Rehydration buffer 8mM Urea (Bio-rad, USA) 
2% CHAPS (Bio-rad, Canada) 
50mM DTT (Fermentas, Canada) 
0.2% Biolyte (Bio-rad, Canada) 
0.5% Bromophenol blue (Sigma, USA) 
 
Table 3: Primer 
Primer name Sequence 5’- 3’ 
3’ RACE forward specific primer CGAGATCTTCTAGAAG 
 
2.2 Tissue culture  
 
The embryonic cell line (SAEIE08) from E. intermedius was cultured in 30ml Grace’s insect 
media to give a concentration of 100cells\ml in the final volume. The cells were incubated at 
25
o
C for 12 hours to reach an exponential growth phase. The cells were treated with 
camptothecin dissolved in DMSO to give a final concentration of 50mM in the insect media. 
DMSO was used as a control treatment. The cells were incubated for a further 4 hours, and 
the cell concentration was estimated to be approximately 5 x 10
6 
cells\ml.  
2.3 RNA extraction 
 
Total RNA for GeneFishing® and RACE was extracted using the ZR RNA MiniPrep kit 
from Zymo Research (catalogue number: R1064) according to the manufacturer’s protocol. A 
cell concentration of approximately 5 x 10
6 
cells\ml was used during the extraction. 
Extraction was performed for both camptothecin and DMSO treated cell cultures. The 
concentration and purity of total RNA was determined through standard spectroscopy and 
formaldehyde RNA gel (1% agarose) (Figure 3). The 260/280 ratio was used to determine the 
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purity of RNA. This ratio was measured using a Nanodrop and measures the level of protein 
contamination. A ratio of greater than 1.8 is acceptable. 
 
 
 
  
Figure 3: Total RNA extracted from the beetle cell culture. The integrity of RNA was determined using 
formaldehyde RNA gel (1% agarose). The gel shows both the 18S and 28S ribosomal RNA.  
2.4 Protein extraction from lysed cells and concentration from the supernatant 
 
Crude proteins from lysed cells were extracted from both the camptothecin treated and 
DMSO treated cell cultures using Tri-reagent from Sigma-Aldrich (catalogue number: 
T9424) following the manufacturer’s protocol. The protein was however, washed in 100% 
ethanol by spinning for 5 minutes at 7500rpm after precipitation and dissolved in rehydration 
buffer for 2-D gel analysis and 1% SDS for C18 column purification. A cell concentration of 
approximately 5 x 10
6 
cells\ml was used for the extraction. The protein concentration was 
determined using the Bradford reagent from Bio-rad (Cat # 10563) and a UV VIS 
spectrophotometer. The Bradford assay was performed according to the manufacturer’s 
protocol. The standard curve (Figure 4) used was determined by Hull, (2012) and constructed 
in the spectrophotometer. The Bradford assay is a method used to determine protein 
concentration. The procedure involves binding of Coomassie Brilliant Blue G-250 dye to the 
proteins. The dye exists in three forms: cationic (red), neutral (green) and anionic (blue) and 
subsequently changes into a stable unprotonated blue form upon binding to proteins. The 
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unprotonated from has a wavelength of 592nm which is the wavelength used to determine 
protein concentration using a spectrophotometer.  
Figure 4: Standard curve for protein concentration using the Bradford assay. The curve was done in technical 
replicates and mean values used to construct the curve in the spectrophotometer. The equation of the line is y = 
0.29564x -0.00004 and R
2
 = 0.9994 (Hull, 2012). 
Secreted proteins were concentrated from the supernatant. Camptothecin treated and 
untreated cell cultures were spun in 15ml centrifuge tubes for 5 minutes at 3.5rpm. The 
supernatant was used to concentrate the secreted proteins using Millipore’s Amicon Ultra-4 
centrifugal filter (Cat # UFC4 LCC 25). The filter enables retention of proteins from dilute 
samples, serum and cell culture samples through the nominal molecular weight limit 
membrane. The proteins were recovered from the bottom of the filter by sucking with a 
pipette. The lysate ~ 250µl was re-suspended in 250µl of 1% SDS. One volume of 20% 
trichloroacetic acid was added and the mixture incubated on ice for 30 minutes. The sample 
was spun at 12.5rpm for 10 minutes. The supernatant was discarded and pellet washed in 
500µl cold acetone by spinning at 12.5rpm for 5 minutes. Acetone was discarded and pellet 
air dried. The pellet was re-suspended in rehydration buffer by pipetting and used in 2-D 
electrophoresis. 
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2.5 Isolation of the cationic amphiphilic proteins 
 
The crude protein extract from the SAEIE08 cell line contains a complex mixture of proteins 
which needs further and specific purification to enable isolation of a specific group of 
proteins. In this study the Chromabond® C18 column from Macherey-Nagel (Cat # 0206/8) 
with a void volume of 0.8ml was used to isolate cationic amphiphilic peptides for radial 
diffusion assays. The column contains a hydrophobic, reverse phase, silica-based bonded 
phase that is capable of adsorbing cationic hydrophobic molecules from aqueous solutions. 
The column was activated with 2 volumes (0.8ml) of methanol. 0.8ml of the crude protein 
extract solubilised in 1% SDS was added to the column using a 10ml syringe and the flow 
through was collected. The column was washed with two volumes (0.8ml) of 5mM sodium 
phosphate buffer pH 8. The column was finally washed with 1ml of 80% acetonitrile in 5mM 
sodium phosphate buffer pH 8. Acetonitrile was removed from the samples through exposure 
to a stream of nitrogen. 
 
2.6 Antimicrobial activity assays 
 
The radial diffusion assays were based on the technique of Leher et al., (1991). Tryptic soy 
broth was inoculated with a single Escherichia coli colony and allowed to grow for 18 hours 
at 37
o
C. 50µl of the culture was used to inoculate 50ml of fresh Tryptic soy broth and this 
was grown further for 3 hours at 37
o
C. The culture was centrifuged and re-suspended in cold 
10mM sodium phosphate buffer. The optical density of the culture was determined at 620nm 
and this was used to calculate the volume required to make a culture with 4 x 10
6
 colony 
forming units per ml in a final volume of 15 ml underlay agar using the formula: 0.2 O.D620nm 
= 5x 10
7
 CFU/ml. 15ml of the underlay agar with bacterial culture was prepared and plates 
were allowed to set. Holes were punched in the agar and the protein samples, tetracycline, 
phosphate buffer, acetonitrile and water controls were added to the holes. Tetracycline is a 
known antimicrobial and was used as the positive control while water was used as a negative 
control. Acetonitrile and phosphate buffer controls were used to verify that the solvents used 
in eluting proteins did not contribute to the antimicrobial activity of the proteins under 
investigation. Protein eluted with acetonitrile and sodium phosphate buffer were used as test 
samples. The plates were incubated for 3 hours at 37
o
C. 15ml of overlay agar was then added 
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and plates incubated for 18 hours at 37
o
C. The diameter of the clearings was measured. The 
assays were performed in triplicates for each test sample and control.  
2.7 Chemical characterisation of the antimicrobial active agent using the Protein kinase 
assay 
 
The inhibitory samples were treated with Proteinase K to determine the nature of the 
antimicrobial active molecules. Proteinase K was added to the samples to the final 
concentration of 100µg/ml. 100µg/ml Proteinase K and water were also included as controls. 
The reactions were incubated at 37
o
C for 15 minutes and Proteinase K was inactivated by 
heating at 70
o
C for 15 minutes.  
The inhibition assay was repeated with the Proteinase K treated samples. Three technical 
replicates were used for each sample in the assays.  
 
2.8 Differential expression of genes after camptothecin treatment 
2.8.1 Genefishing Technology 
 
The cDNA of differential expressed genes was synthesised using a GeneFishing® kit from 
SeeGene® (Catalogue number: K1026). The kit enables the identification of differentially 
expressed genes in 2 or more RNA samples. The kit works in three steps, which consist of the 
first strand cDNA synthesis step and a two-stage PCR. These steps use a set of three unique 
annealing controlled primers (Figure 5). The first step applies reverse transcription using dT-
ACP 1 to synthesize cDNA from the mRNA. The 3΄ end hybridizing sequence of dT-ACP 1 
is complementary to the mRNA poly A tail and this results in a first strand cDNA transcript 
with the universal sequence of dT-ACP 1 at its 5΄ end. The first strand cDNA is then diluted 
and placed in tube with an arbitrary ACP and dT-ACP 2 for the PCR step. The first PCR 
stage is a single PCR cycle under conditions that enable only the annealing of the arbitrary 
ACP with its 3΄ end core to the first strand cDNA. This results in a second-strand cDNA with 
a complementary sequence of the universal sequence of dT-ACP 1 on its 3΄ end and the 
universal sequence of the arbitrary ACP on its 5΄ end. The second PCR stage enables the 
amplification of the targeted PCR product only. The conditions are set to exclusively allow 
both dT-ACP 2 and the arbitrary ACP to anneal to the 3΄ and 5΄ ends of the second strand 
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cDNA, respectively. The conditions also prevent the annealing of both primers to the first 
strand cDNA. The gene fishing experiment was performed following the manufacturer’s 
protocol. The PCR products were electrophoresed in 1% agarose gel with ethidium bromide 
in 2X TAE electrophoresis buffer at 100Volts. A 1Kbp plus marker was used.The gel was 
kept for the recovery and purification of differentially expressed genes/bands. 
 
Figure 5: Flow chart of cDNA synthesis and GeneFishing® PCR (SeeGene® GeneFishing
TM
 DEG premix kit 
user manual 2005, Catalogue number: K1026). 
 
 
First strand cDNA 
synthesis 
First stage PCR for second 
strand cDNA synthesis. 
Only the arbitrary ACP 
binds to the first strand 
cDNA 
Second stage PCR to amplify target 
PCR products. The conditions are 
set to enable exclusive annealing of 
both primers to the second strand 
cDNA only 
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2.8.2 PCR products recovery and purification from electrophoretic gels 
 
 DNA purification from the gel was performed using with the Zymogen DNA recovery kit 
(Cat # D 4001). The kit provides an efficient method for high quality DNA purification and 
concentration from agarose gels without the use of organic denaturants. The kit purifies and 
concentrates DNA in a fast spin column. The bands of differentially expressed genes from 
gene fishing were excised from the gel under UV-light illumination. The purification was 
carried out following the manufacturer’s protocol.  
2.9 Cloning and sequencing of the GeneFishing® PCR product 
2.9.1 Cloning 
 
The recovered DNA was eluted with RNAase free water and cloned into a pGEM-T Easy 
Vector since gene fishing PCR products have poly-A tails. The ligation reaction was set-up 
according to the manufacturer’s protocol.  The total amount of insert DNA used was 25ng for 
each reaction. The tubes were sealed with parafilm and placed under water to prevent 
evaporation in the tube. The reaction was incubated for 12 hours at 4
o
C and inactivated by 
incubating at -70
o
C for 15 minutes  
10µl of the ligation reaction was added to 40µl competent cells on ice, and was left to stand 
for 30 minutes. The cells were heat shocked for 45 seconds at 45
o
C and cooled on ice for 2 
minutes. 960µl of the recovery medium was added and the mixture was incubated at 37
o
C 
with shaking at 250rpm for 90 minutes. 100µl of the transformation reaction was plated on 
pre-warmed agar with ampicilin/X-gal and IPTG. X-gal/IPTG was spread on the agar plate 
30 minutes before plating and plates pre-warmed at 37
o
C.  
2.9.2 Sequencing  
 
Gene fishing PCR products cloned in bacterial cells were sent to Inqaba Biotech® for 
sequencing. 
2.10 3’ Rapid amplification of cDNA Ends 
 
Sequencing produced a partial sequence of a differentially expressed transcript which was 
used in 3’ RACE to synthesise a full-length transcript of the gene (Figure 4).  This technique 
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enables the generation of a full length sequence of RNA from cultured cells. The cDNA is 
generated using an Oligo-dT primer complementary to the natural polyA tail on 3′end of an 
mRNA transcript. The mRNA is then degraded before the PCR step. This technique was used 
because the PCR step requires only one specific primer (forward primer) and an anchor 
primer. A forward primer was designed from the partial sequence (Figure 10). The 3` RACE 
was performed using the 5΄\3΄ RACE kit, 2nd generation from Roche® (Cat # 03 353 621 
001) according to manufacturer’s protocol. The full-length sequence of the gene fishing 
transcript was amplified from total RNA from camptothecin treated cells. The PCR 
amplification program was performed as follows: Initial denaturation at 94
o
C for 3 minutes, 
denaturation at 94
o
C for 30 seconds, annealing at 60
o
C for 30 seconds, 40 cycles of 
elongation at 72
o
C for 45 seconds, and a final elongation at 72
o
C for 5 minutes. PCR products 
were separated with electrophoresis. The whole PCR reaction was sent for sequencing by 
Inqaba biotech®. 
 
Figure 6: Overview of 3’ RACE (Roche® Applied Science 5’\3’ RACE kit, 2nd generation manual, Version 
October 2005, Cat # 03 353 621 001). 
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2.11 Proteomic analysis of molecules involved in genotoxic response of E. intermedius 
embryo cell line 
2.11.1 2-D electrophoresis 
 
A protein concentration of 100µg/ml was used for 2-D analysis. The protein sample was 
pipetted along the length of the rehydration tray and an 11cm IPG strip (pH 3-10) was laid 
carefully facing down avoiding the formation of bubbles. The strip was overlaid with mineral 
oil, sealed with parafilm and left to stand for 20 hours at room temperature. The wire 
electrodes of the isoelectric focusing tray were each covered with a paper wick and moistened 
with ~10µl of nanopure water. The IPG strip was removed from the rehydration tray and held 
for about 20 seconds to allow the mineral oil to drip off. The strip was placed facing down in 
the channel of the isoelectric focusing tray with its positive side on the anode left side of the 
tray. The strips were covered with mineral oil. The isoelectric focusing was performed in 
three steps. The first step was done at 250 Volts for 20 minutes with linear ramping, the 
second step at 8000 Volts for 2.5 hours with linear ramping and the last step was rapid 
ramping for 20000 Volts-hour. The IPG strip was removed from the isoelectric focusing tray 
and placed in a rehydration tray. 2 ml of equilibrating buffer I was added to the channel with 
the strip and shaken gently for 5 minutes. The buffer was discarded and replaced with 
equilibrating buffer II. The tray was gently shaken for 5 minutes and the buffer discarded. 
The strip was removed and dipped for about 30 seconds in 1X SDS running buffer in a 
measuring cylinder. The strip was over-laid on a precast gel. A paper wick loaded with 2µl 
pre-stained protein marker was placed next to the IPG strip. Overlay agarose was added and 
allowed to solidify. The PAGE was run at 100 Volts in 1X SDS running buffer. The gel was 
stained in Coomassie brilliant blue for 14 hours. The dye was de-stained for 4 hours and 
washed for 5 hours with several changes of distilled water.  
2.11.2 Image analysis 
 
A PDQuest 2-D analysis software version 6.2 (Bio Rad Cat #170-9630) was used to scan and 
upload the gel images. The camptothecin treated gel was used as the master gel. The spots 
from the camptothecin and DMSO treated gels were initially matched using the automated 
matching function. The spots were further matched manually with manual matching functions 
that enable deletion and addition of spots not detected or improperly detected during 
automated matching. Normalization was done automatically by the program based on the 
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given normalization formula: Normalized spot quantity = Raw spot quantity x scaling factor / 
Normalization factor (total quantity in all valid spots). The scaling factor was 10
6
 parts per 
million 
2.11.3 Mass spectroscopy 
 
Spots representing differential expression were excised from the gels and sent for LC MS 
mass spectroscopy analysis at the Council for Scientific and Industrial Research, Pretoria, 
South Africa. The trypsin digested peptides were analysed using a Dionex Ultimate 3000 
RSLC system coupled to a QSTAR ELITE mass spectrometer. Peaks v6.0 search engine 
(Bioinformatics Solutions Inc.) was used for comparison of the obtained MS/MS spectra with 
the MS protein sequence DataBase (MSDB) as well as the Flylab genome base. A False 
Discovery Rate (FDR) of 0.1% was used and proteins with more than one unique peptide 
reported. 
2.11.4 Statistical and bioinformatics analysis 
 
The mean OD values from the 2-D gels were calculated and changes in the expression of 
individual peptides were analysed using a one sided Wilcoxon Signed-Rank test at 10% 
significance level to compare differences in the mean since the data distribution is not 
normal. The Wilcoxon Signed-Rank t-test was also used to compare the differences in the 
mean inhibition in the activity assay. Peptide fingerprints from MS/MS were identified 
through manual search from the flylab genome base database 
(http://flylab.wits.ac.za/EI/est2uni/blast.php) (Khanyile et al., 2008) consisting of EST 
sequences of the adult transcriptome using TBLASTN. A BLAST was also performed from 
the National Centre for Biotechnology Information (NCBI) database (www.ncbi.nlm.nih.gov) 
using the UnitProtKB/Swiss-Prot(swissprot) database to identify proteins that had similar 
sequences to those identified by mass spectroscopy.  
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Chapter 3: Results 
3.1 Results 
 
The primary objective of the study is to investigate whether CAPs are activated by 
camptothecin and the molecular pathways involved in the process. GeneFishing® and 2-D 
analysis were used to determine the changes in gene expression at transcription and 
translation levels, respectively. 
CAPs are an interesting group of molecules that are reported to play roles in apoptosis, stress 
response and to possess cancer selective toxicity as reviewed in this study. Moreover, it is in 
the view of this study that an understanding of the molecules and/or pathways involved in 
DNA damage paves a way for their exploitation to design novel cancer selective therapeutics. 
The objective of this study was to use GeneFishing
®
 and 2-D gel analysis to analyse 
molecules involved in genotoxic stress response in an E. intermedius embryo cell line and to 
establish if the induction of CAPs is part of the response. 
3.2 Antimicrobial activity assays 
 
Genotoxic stress induces a series of response pathways in cells. The molecules induced in 
these response mechanisms are activated to either reverse the damage caused by the stress or 
cause cell apoptosis. This experiment aims to establish whether CAPs are specifically 
induced in response to genotoxic stress. In order to determine whether CAPs were expressed 
by the cell line, the C18 elutes of crude extracts from induced and un-induced cell cultures 
were assayed for anti-bacterial activity. This approach was used because CAPs are expected 
to have anti-bacterial activity.   
The SAEIE08 cell line was used as a model in this study. The cell line was treated with 
camptothecin. The characteristic amphiphilic and cationic nature of CAPs was exploited to 
exclusively separate them from the crude protein extract from cell cultures using the C18 
column. The column is designed to adsorb cationic hydrophobic molecules from an aqueous 
solution. Radial diffusion assays were subsequently used to determine whether camptothecin 
treatment induced molecules that possess anti-bacterial toxicity. The Gram negative, E.coli 
was used as a model for the toxicity assay because CAPs anti-bacterial activity employs the 
same mechanisms of action as during anti-proliferative activity against cancer cells. The 
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above is attributed to similarity in the overall characteristic of the membrane of cancer and 
bacterial cells.   
Microbial inhibition was present in the samples eluted with acetonitrile (Figure 7a). This 
shows that the inhibitory molecules are cationic and amphiphilic which is consistent with the 
character of most CAPs. Interestingly acetonitrile purified samples from both camptothecin 
treated and untreated crude extracts showed microbial inhibition. This indicated constitutive 
expression of antimicrobial activity. However, inhibition by the former was significantly 
higher since the same concentration of the protein was used in the assays (T value = 0 < 
Tcritical=2, for n = 3) (Figure 7a). This indicated that more activity was induced by 
camptothecin. Water was included as a standard negative control to enable comparison 
between microbial inhibition and non-inhibition (Figure 7b). No inhibition was shown in the 
water, sodium phosphate and acetonitrile control. Sodium phosphate and acetonitrile were 
included as controls since they were essential components of the elution buffers used to elute 
the proteins from the C18 column (Figure 7c). The positive control, tetracycline showed 
significant microbial inhibition (Figure 7c). Overall, the results show that the inhibitory 
molecules are constitutively active in the cells and that further expression is induced in 
response to camptothecin treatment. The constitutive activity may be attributed to the 
microbe-rich environment in which the beetles live. 
To investigate the nature of the antimicrobial active molecules, the samples showing 
microbial inhibition were treated with Proteinase K. No antimicrobial inhibition was shown 
following the treatment of the inhibitory sample with Proteinase K (Figure 8a). This implies 
that the antimicrobial inhibition is a consequence of a protein since Proteinase K degrades 
proteins. Proteinase K alone also showed no inhibition (Figure 8c). Microbial inhibition was 
however, observed from untreated sample and from the tetracycline control.  
Given these results, it may be proposed that probable cationic amphiphilic proteins are 
constitutively expressed by the cells and that camptothecin induces the production of more 
proteins. 
The above observations pave the way to further study the pathways involved in the up-
regulation of the anti-bacterial activity and to determine whether the induction of CAPs is 
part of the pathways and if they also play a role in genotoxic stress. 
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Figure 7: Radial diffusion assays. The crude protein extracts from E intermedius cells treated with 
camptothecin and untreated cells were purified with a C18 Sep pak vac column eluting with sodium phosphate 
buffer and acetonitrile. Figure 7 A shows inhibition by the acetonitrile purified samples. However, the sample 
from proteins extracted from camptothecin treated cells shows enhanced inhibition compared to the sample from 
the proteins extracted from untreated cells. T value = 0 < Tcritical=2, for n = 3. The negative controls and 
positive control (tetracyclin) are represented in Figure 7 B and C.   
 
 
 
 
 
 
 
 
Figure 8: Characterisation of the inhibitory or toxic molecule. The sample that showed inhibition in the radial 
diffusion assay was treated with Proteinase K to verify that a peptide was responsible for the antimicrobial 
activity. Radial diffusion assays were used to test for microbial inhibition after treatment with Proteinase K. 
Figure 8A shows that no inhibition was seen after treatment with Proteinase K for both camptothecin treated and 
untreated samples. Similarly Figure 8 B and C show no inhibition by the controls.  
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3.3 Differential transcription of genes induced by camptothecin 
 
Following the confirmation that the SAEIE08 cell line up-regulates the expression of 
probable antimicrobial proteins, the gene fishing technique in combination with 3’ RACE 
was used to determine the identity of differentially transcribed genes following camptothecin 
exposure. The principle of gene fishing is based on the use of an annealing control primer 
(ACP) that anneals with high specificity to the intended template to allow amplification of the 
target product. The ACP is a tripartite structure with distinct 3΄- and 5΄-end portions 
separated by a regulator. The 3΄-end core is designed to target the template via the 
hybridising sequence and is significantly complementary to a portion on the target nucleic 
acid template. The 5΄-end core has a universal sequence and together with the regulator plays 
an important role in the annealing of the ACP to the template. RNA samples from 
camptothecin treated cells and from untreated cells were used in the gene fishing to identify 
differential expression between the two RNA samples (Figure 5).  Electrophoresis was used 
to separate PCR products generated in the gene fishing experiment. The partial sequence of 
the up-regulated transcript generated by ACP 17 was used to design a forward primer to 
synthesise a full-length transcript of the gene using 3΄ RACE (Figure 6).  The full length 
sequence of the gene was generated from the RNA of camptothecin treated cells. The PCR 
product was separated by electrophoresis. The whole PCR reaction containing two bands was 
sent for sequencing by Inqaba Biotech®.  
Camptothecin exposure also resulted in differential transcription of certain genes. Arbitrary 
complementary primers (ACP) 16- and 19-amplified fragments (300bp and 200bp, 
respectively) show down-regulation in the transcription of genes following campthotecin 
treatment (Figure 9b). Furthermore, ACP 17-amplified fragment (100bp) showing up-
regulation in gene transcription (Figure 9b). ACP 18 also produced an up-regulated gene of ~ 
250bp (Figure 9b).  
The ACP 17-amplified transcript was cloned in pGem T-easy vector. Sequencing of the 
transformed clones produced a partial sequence of the gene. The sequence was subsequently 
used to design a forward primer (Figure 10) that was then used to perform 3’ RACE to 
amplify the full sequence of the gene. Sequencing of the RACE PCR product produced two 
sequences and this is consistent with the two products shown in the electrophoretic gels 
(Figure 11). Only one of the sequences gave a likely match following a BLAST search in 
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NCBI nucleotide database. The sequence was highly similar to a yeast Yph1p protein 
homologue. Gene fishing coupled with 3’RACE results suggest that the gene for the Yph1p 
protein is constitutively expressed and also induced by camptothecin. 
 
 
 
A      
 
 
 
B  
Figure 9: Gene fishing to identify differentially transcribed genes between camptothecin treated (T) and 
untreated/normal cells (U). Figure 9 A shows the arbitary complementary primers that amplified transcripts 
produced in response to camptothecin treatment in comparison to untreated\normal cells. B is a composite figure 
of figure A. The solid arrow shows the down-regulated transcript amplified with ACP 16. The dotted arrows 
show up-regulated transcripts amplified by ACP 18 and ACP 19. 
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5’ CGAGATCTTCTAGAAG 3’ 
Figure 10: Chromatogram showing the ACP 17 generated partial transcript that was used to design the forward 
primer for 3’ RACE. 
 
 
 
 
 
                                                
Figure 11: Rapid Amplification of cDNA Ends (3’ RACE) of the partial sequence obtained from differentially 
transcribed transcripts using the ACP17 GeneFishing® primer. The cDNA was amplified with a forward 
specific primer and PCR anchor primer. The gel shows two significant bands, one ~460bp and the other ~250bp. 
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3.4 2-D analysis of molecules involved in genotoxic response of E. intermedius embryo 
cell line 
 
The activity assays showed that camptothecin treatment results in the up-regulation of the 
expression of proteins with CAP-like characteristics. As shown above, gene fishing results 
revealed that there were changes in gene transcription following camptothecin treatment to 
the cells (Figure 9). 2-D gel analysis and mass spectroscopy were subsequently used to 
identify the changes in protein expression following the exposure of the cells to 
camptothecin. The same concentration of the crude protein from camptothecin treated cells 
and non-treated cell cultures were separately exposed to 2-D electrophoresis on 11 cm pH 3-
10 IPG strips. The 2-D gels for both camptothecin-treated and untreated samples were 
digitised using 2-D gel analysis software, PDQuest
(R)
. The spots that were validated by 
PDQuest
(R)
 software to be differentially expressed were excised from the gels and sent for 
sequencing using mass spectroscopy. The MSDB identified proteins were sorted according to 
their biological functions (Table 4). Furthermore, the peptide finger prints from mass 
spectroscopy were used to manually search the NCBI and Flylab genome base database 
(Table 5). The comparison in table 5 is important to enable genes to be cloned from adult 
beetles using sequences in the flylab genome base database since the database contains EST 
sequences of adult transcriptome of E. intermedius. 
Gene fishing and 2-D gel analysis represented by Figure 7b and Figure 12, respectively show 
that camptothecin exposure leads to differential expression of certain genes. Gene expression 
analysis showed changes in the expression of a range of protein classes such as stress 
proteins, immunophilins, translation proteins, oxidative metabolism proteins, mitochondrial 
proteins and cytoskeletal proteins.  
The expression of stress response proteins such as ubiquitin and heat-shock protein were up-
regulated. There was a significant down-regulation of oxidative metabolism proteins such as 
ATP synthase and ADP/ATP synthase. The expression the glycolytic enzyme, 
glyceraldehyde-3-phosphate dehydrogenase was also down-regulated. Cytoskeletal proteins 
were both up-regulated and down-regulated. For instance myosin light chain was up-
regulated while myosin heavy chain was down-regulated. Protein translation associated 
proteins such as upf 1 membrane protein, ribosomal protein S14e and elongation factor 1-
alpha and mitochondrial maintenance protein, mmf 1 were up-regulated.  
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Figure 12: 2-D electrophoresis analysis of differential expression of proteins between untreated (A) and 
Camptothecin-treated (B) in South African Euoniticellus intermedius embryonic cell line. Exponentially 
growing cells were treated with 50mM camptothecin and the crude protein extracted from cells after 4 hours 
using Trizol reagent.  The isoelectric focusing was done with an 11 cm IPG strip and the 2
nd
 dimension was run 
using a precast TGX gel from Biorad®. Spots numbered in Red are only present in the untreated (A) gel, spots 
marked in dark blue with a rectangle are found in treated only (B) and spots marked in blue are found in both 
gels.  
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Table 4. Proteins identified with MSDB and BLAST searches in NCBI database and Flylab base genomebase. 
Camptothecin exposure resulted in both up-regulation and down-regulation of protein expression. A one sided 
Wilcoxon Signed-Rank test at 10% significance  level to verify if there was a significant change in the levels of 
protein expression between camptothecin treated cell line and untreated cell line. A T-value less than Tcritical  
indicates a significant difference in protein expression. Tcritical = 2. 
Spot MSDB predicted protein 
Spot 
MR 
(Kda) Flylab genomebase matching peptide 
Mean 
OD 
before 
Mean 
OD 
after T-value 
Stress proteins       
2309 Yeast heat shock protein 20  4.8 75.2 0 
5202 Ubiquitin 8  109.1 131.1 1 
4203 Un-identified 11 Tribolium mrj (100%) 62.3 0.2 0 
4203 Ubiquitin-60S ribosomal protein 11.5  62.3 0.2 0 
Oxidative 
metabolism 
and 
mitochondrial       
7307 Mitochondrial peroxiredoxin 13  119.6 0.2 0 
8303 Protein mmf1 mitochondrial 14.5  154.1 0.2 0 
       
8303 Glyceraldehyde-3-phosphate deyhdrogenase 14.5  154.1 0.2 0 
7202 ATP synthase 7  158.5 3.1 0 
7202 ADP/ATP translocase 7  158.5 3.1 0 
Protein 
translation       
1203 ribosomal rna small subunit methyltransferase 7.5 Glycosyl hydrolase family (100%) 44.2 121.8 0 
5205 Un-identified 12.5 Elongation factor 1-alpha (100%) 13.8 57.9 1 
5206 40S ribosomalprotein S14 8 Putative ribosomal protein S14e (100%) 0.3 88.1 0 
9301 upf 1 membrane protein 17 Myosin heavy chain isoform 2 (100%) 0.3 124.3 0 
3207 eukaryotic translation initiation factor 3 subunit 11  57.5 114.4 0 
Cytoskeletal 
protein       
3207 Un-identified 11 Similar to Tropomyosin 1 (100%) 57.5 114.4 0 
1215 myosin light chain 12 Myosin alkali light chain 1(100%) 10.4 37.6 1 
7202 myosin heavy chain 7  158.5 3.1 0 
6207 actin fragment 6.5  86.1 125.1 1 
Immunophilins       
3204 FK506 Binding protein 7 FK506 Bingding protein (100%) 58.6 116.7 0 
7201 Un-identified 7.5 Cyclophilin 1 (71%) 392.7 0.2 0 
 
 
 
- 37 - 
 
Table 5: Comparison of MS database identified proteins with the NCBI and Flylab base genomebase databases 
identified proteins.  
Spot NCBI predicted protein 
Accession 
number Flylab genomebase matching peptide Flylab  genome DB ID 
2309 Heat shock 70 kDa protein P12795.1   
5202 Ubiquitin P19848.1   
4203   Tribolium mrj (100)  
4203 Ubiquitin -60S ribosomal protein L40 P0CH08.1   
7307 Mitochondrial peroxoredoxin PRX1 P34227.1   
8303 Protein mmf1 mitochondrial P40185.1   
8303 Glyceraldehyde-3-phosphate dehydrogenase  P17819.1   
7202 ATP synthase F1 sector subunit beta B0THN2.1   
7202 ADP/ATP translocase P05141.7   
1203 ribosomal rna small subunit methyltransferase Q4FPN5.1 Glycosyl hydrolase family (100%) 005275_1537_3307_c_s 
5205 Elongation factor 1-alpha Q07051.1 Elongation factor 1-alpha (100%) CL17Contig1 
5206 40S ribosomalprotein S14  P27069.1 Putative ribosomal protein S14e (100%) CL171Contig1 
9301 Buforin 1 P55897.1 Muscle myosin heavy chain isoform 2 (100%) CL448Contig1 
3207 Eurkaryotic translation initiation factor 3 subunit P23301.3   
3207 Tropomyosin P42637.1 Similar to Tropomyosin 1 (100%) CL137Contig1 
1215 Myosin-2 light chain P53141.1 (Tribolium) Myosin alkali light chain 1(100%) CL25Contig1 
7202 myosin heavy chain D P02567.3   
6207 actin 1 P85911.1   
3204 FK506 Binding protein Q754K8.1 FK506 Bingding protein (100%) 009937_1646_3733_c_s 
7201 Cyclophilin P14832.3 Cyclophilin 1 (71%) 005522_1647_2340_c_s 
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Chapter 4: Discussion 
4.1 Discussion 
 
This study shows that the SAEIE 08 cell line constitutively expresses antimicrobial proteins. 
Moreover, more anti-bacterial proteins are induced upon challenge by camptothecin. Analysis 
of gene expression has not revealed any cationic peptides as expected but showed classes of 
biological molecules involved in a range of pathways. Gene fishing and 2-D gel analysis 
showed changes in the expression of proteins involved in stress response, oxidative 
metabolism, mitochondrial maintenance, cellular regulation and protein translation, following 
camptothecin exposure of the E intermedius embryonic cell line.  
4.2 Cationic peptides detection 
 
The C18 column was used to isolate cationic amphiphilic molecules expressed in the cell line 
before and after treatment with camptothecin. Radial diffusion assay and Proteinase K assay 
were then used to determine if the molecules have any antimicrobial activity and the nature of 
the molecules, respectively.  
The microbial inhibition in the bioassays from samples eluted with acetonitrile demonstrated 
the presence of an antimicrobial molecule which is cationic and amphipathic. The C18 
column contains a hydrophobic, silica-based bonded phase that is capable of adsorbing 
cationic hydrophobic molecules from aqueous solutions, and hence it requires a strong polar 
aprotic solvent to elute them. Furthermore, the Proteinase K assay verified that this inhibitory 
molecule is a protein. Bacterial cells were used as a model for the toxicity assays because 
cancer cells, like bacterial cells, have negatively charged phospholipid membranes which are 
targets of the cationic peptides (Hancock, 2001; Leuschner and Hansel, 2004). The 
electrostatic attraction between the negatively charged membranes and the cationic peptides, 
and the amphipathicity of the peptides play a major role in the membrane-localised mode of 
action of the cationic amphiphilic peptides (Jang et al., 2011; Lohner and Prossnigg, 2009). 
Although the study showed the induction of probable cationic amphiphilic proteins with 
antimicrobial activity, cationic amphiphilic peptides were not identified.  
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4.3 Changes in gene expression induced by genotoxic stress 
 
Gene fishing and 2-D gel analysis were used to analyse the changes in gene expression 
following the exposure of the cell line to camptothecin. RNA samples from camptothecin-
treated and untreated cell culture were used in GeneFishing® to identify changes in 
expression from a transcriptional level. Protein samples from camptothecin treated and from 
untreated cells were used in 2-D analysis to identity changes in expression at a translational 
level. The protein identities from mass spectroscopy were analysed and grouped according to 
their biological functions.  
Overall gene expression analysis showed that there were significant changes in protein 
expression following camptothecin treatment. These changes in protein expression occurred 
particularly in the expression of proteins involved in stress response, oxidative metabolism, 
protein translation and cytoskeletal proteins. 
Cell cycle regulator 
Gene fishing and 3′ RACE resulted in the identification of a gene encoding a yeast Yph1p 
protein homologue. The expression of this gene was shown to be up-regulated. Yph1p is an 
88 kDa protein and is highly conserved across species. Yph1p has been established to form 
complexes with proteins involved in cell cycle regulation, 60S ribosomal subunit biogenesis, 
DNA replication and regulation of chromatin structure, hence suggesting that the protein 
plays a critical role in these respective cellular processes. Interestingly, the mammalian 
ortholog of the protein has been shown to be up-regulated in metastatic cancer tissues giving 
further evidence to support its role in DNA replication, cell cycle regulation and checkpoint 
control (Du and Stillman, 2002).  
Yph1p has been established to have two domains, a coiled-coil BRCT domain and a putative 
bipartite nuclear localisation signal domain (Du and Stillman, 2002). The former was first 
discovered at the C-terminus of the breast cancer protein BRCA1. A significant number of 
proteins have been found to have at least one BRCT motif and most of them have been 
suggested to have roles in cell cycle regulation, checkpoint control, and DNA damage repair. 
The BRCA1 BRCT domain interacts directly with a phosphorylated BRCA1 associated 
carboxyl terminal helicase, and this interaction is specifically cell cycle regulated and critical 
for DNA damage induced checkpoint control (Yu et al., 2003). 
- 40 - 
 
Since Yph1p contains a BCRT domain which is also found in most proteins with roles in cell 
cycle regulation, and DNA repair and regulation (Yu et al., 2003), the up-regulation of Yph1p 
in this study may be induced by the reported DNA damage caused by camptothecin treatment 
to normal cells (Hull and Ntwasa, 2010).  
Stress response proteins 
Camptothecin exposure resulted in significant changes in the expression of stress proteins. 
The yeast heat-shock protein up-regulated in cells following exposure to camptothecin is a 
general stress protein induced when cells are exposed to temperatures slightly higher than 
their optimum growth temperature, or by a range of other environmental stresses such as 
genotoxic stress, inflammation and oxidative stress. For this reason they are also known as 
stress proteins (Verghese, 2012; Lindquist, 1984). The expression of ubiquitin was up-
regulated following exposure to camptothecin. Ubiquitylation regulates many cellular 
processes including DNA repair pathways, damage avoidance mechanisms, cell cycle 
checkpoints, apoptosis (Bergink and Jentsch, 2009) and may be associated with genotoxic 
stress since it is up-regulated in this study.  
An interesting observation was the down-regulation of MRJ protein. This protein is a member 
of the DNAJ/heat shock protein 40 family of chaperones (Hunter et al., 1999). Watson et al., 
(2007) showed that MRJ deficiency inhibits normal keratin turnover promoting the formation 
of large toxic keratin aggregates thus inhibiting the normal function of the trophoblast. This 
suggests a role of MRJ in preventing the formation of toxic inclusion bodies. Moreover, 
Andrews et al., (2012) showed that an MRJ small variant that is localised in the cytoplasm is 
capable of translocating to the nucleus in response to heat shock and hypoxia. Thus, MRJ is 
likely to be a heat shock protein that specifically responds to cellular stress and plays a 
limited role in genotoxic stress since it was down-regulated in this study. Furthermore, it is 
likely down-regulated to promote cell death in cells that have been damaged by 
camptothecin.  
Immunophilins 
Camptothecin exposure resulted in changes in the expression of FK506 binding protein and 
Cyclophilin A belonging to the immunophilin family. These proteins have similar roles such 
as receptor signalling, protein trafficking, transcription and regulation of other protein 
activity (Bang et al., 2008; Obchoei et al., 2011). 
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The expression of an FK506 binding protein was up-regulated in response to camptohecin 
treatment. FK506 binding proteins are a family of proteins that bind to FK506, an 
immunosuppressant drug. They act as immunomodulators when in complex with specific 
ligands. Recently they have been established to have roles in apoptosis through molecular 
interactions with receptors (Bang et al., 2008). Moreover, Aghdasi et al., (2001) established 
that the FK506 binding protein 12 is a physiological regulator of the cell cycle. They showed 
that the protein was a subunit of transforming growth factor beta and that the deletion of this 
protein resulted in cell cycle arrest in the G1 phase in mice fibroblasts.  
In contrast to FK506 binding protein up-regulation, cylophilin A, another major 
immunophilin was down-regulated following camptothecin exposure. Cyclophilin A is 
multifunctional protein with similar roles to FK506 binding protein (Obchoei et al., 2011). 
The protein is also up-regulated in response to a range of inflammatory conditions. 
Furthermore, cyclophilin A secretion was established to be induced by oxidative stress via the 
activation of extracellular responsive kinase1/2 (Satoh et al., 2010). Cyclophilin A has also 
been reported to protect cells from hypoxia and infection (Obchoei et al., 2011). 
In this study, the up-regulation of an FK506 binding protein may be associated with the 
increase in gene expression since some FK506 binding proteins have been reported to have 
roles as chaperones (Kang et al., 2008).   
Oxidative metabolism and mitochondrial proteins 
Treatment of the cell line with camptothecin resulted in the down-regulation proteins 
involved in oxidative metabolism and mitochondrial maintenance. ATP synthase, ADP/ATP 
translocase, glyceraldehyde-3-phosphaste dehydrogenase, mitochondrial peroxiredoxin and 
mitochondrial matrix factor-1 protein were shown to be down-regulated. The apparent down-
regulation of certain proteins involved in oxidative metabolism observed in this study is 
different from the increase in oxidative metabolism observed in the Drosophila system after 
camptothecin treatment.  
The down-regulation of mitochondrial peroxiredoxin, an H2O2 scavenger (Castro et al., 2011) 
may be a genotoxic stress response mechanism. High levels of H2O2 have been reported to 
induce cell death (Nonn et al., 2003). Moreover, Sung et al., (2011) reported that 
mitochondrial peroxiredoxin-3 is a potential target for novel cancer therapeutics since 
deletion (RNA silencing or expression knockdown) of peroxiredoxin-3 in HeLa cells 
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increased H2O2 concentration and ultimately increased sensitivity to cell death. Since 
camptothecin is known to increase the production of H2O2 (Hull and Ntwasa, 2010), the 
down-regulation of peroxiredoxin observed in this study may be related to H2O2 sensitive cell 
death. In this study, however, cell death was not investigated but inferred from studies in 
other organisms.  
Protein translation 
Camptothecin exposure resulted in up-regulation of ribosomal RNA small subunit 
methyltransferase, Upf 1 membrane protein, the eukaryotic translation initiation factor 3 
subunit, translation elongation factor-1-alpha and ribosomal protein s14. The up-regulation of 
proteins involved in protein translation is consistent with the new expression of genes.  
Cytoskeletal proteins 
Camptohecin exposure induced higher expression of cytoskeletal protein such as 
tropomyosin, myosin light chain and actin in the cell line. Camptothecin treatment may be 
leading to increased tropomyosin expression in order for the cell to remain viable (Polevoda 
et al., 2003). Furthermore, these cells are not cancer cells even though they are a rapidly 
dividing immortal cell line, hence the increased expression of cytoskeletal proteins observed 
in this study may be important to maintain membrane integrity and cell viability following 
camptothecin treatment.   
4.4 Camptothecin treatment and differential protein expression summary 
 
Gene fishing and 2-D gel analysis showed changes in gene expression at transcription and 
translation levels, respectively following camptothecin treatment. Gene expression analysis 
has shown that E. intermedius cell line alters the expression of stress proteins, oxidative 
phosphorylation proteins, mitochondrial maintenance proteins, translation proteins, 
cytoskeletal proteins and immunophilins to deal with the effects of camptothecin treatment. 
However, the expression of probable cationic amphiphilic peptides was not revealed by this 
analysis. Moreover, the induction of stress response proteins can be related to changes in the 
cell metabolism and morphology following camptothecin exposure.  
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4.5 Conclusion 
Although no novel CAPs were directly identified, the results showed that the cell line 
constitutively expressed probable cationic amphiphilic peptides which are further induced by 
camptothecin. Furthermore, camptothecin induced the differential expression of a well-
known antimicrobial peptide, Buforin 1. 
4.6 Future prospect 
 
Since CAPs were not identified in the lysed cells protein extract, attempts were made to 
isolate and determine the activity of secreted CAPs. Secreted proteins were concentrated 
from the supernatant as describes in the materials and methods chapter. However, activity 
assays could not be performed since the protein yield from the cell culture media was 
significantly low. Furthermore, 2-D gel analysis resulted in low sensitivity to staining and 
poor resolution of the gels as result of low protein yields and high salt concentration in the 
protein samples. The use of an ultra-filtration protein isolation technique that combines 
desalting and concentration in a single step may reduce the salt concentration and increase the 
protein yield. Thus a high protein yield of secreted proteins may enable the detection and 
isolation of CAPs. 
The use of fluorescence staining techniques instead of Coomassie and silver staining may 
increase sensitivity in detecting CAPs from 2-D gels.  
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